nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—CA4—nerve—acquired immunodeficiency syndrome	0.00789	0.104	CbGeAlD
Metolazone—CA7—digestive system—acquired immunodeficiency syndrome	0.00571	0.0752	CbGeAlD
Metolazone—CA9—digestive system—acquired immunodeficiency syndrome	0.00501	0.0661	CbGeAlD
Metolazone—SLC12A3—lung—acquired immunodeficiency syndrome	0.00467	0.0616	CbGeAlD
Metolazone—CA12—digestive system—acquired immunodeficiency syndrome	0.00371	0.0489	CbGeAlD
Metolazone—CA7—brain—acquired immunodeficiency syndrome	0.00337	0.0445	CbGeAlD
Metolazone—CA5B—blood—acquired immunodeficiency syndrome	0.00317	0.0418	CbGeAlD
Metolazone—CA12—lung—acquired immunodeficiency syndrome	0.0031	0.0408	CbGeAlD
Metolazone—CA5B—vagina—acquired immunodeficiency syndrome	0.00294	0.0387	CbGeAlD
Metolazone—CA12—nervous system—acquired immunodeficiency syndrome	0.00287	0.0378	CbGeAlD
Metolazone—CA5B—lung—acquired immunodeficiency syndrome	0.00278	0.0366	CbGeAlD
Metolazone—CA12—central nervous system—acquired immunodeficiency syndrome	0.00276	0.0364	CbGeAlD
Metolazone—CA5B—nervous system—acquired immunodeficiency syndrome	0.00257	0.0339	CbGeAlD
Metolazone—CA5B—central nervous system—acquired immunodeficiency syndrome	0.00248	0.0327	CbGeAlD
Metolazone—CA4—digestive system—acquired immunodeficiency syndrome	0.0023	0.0303	CbGeAlD
Metolazone—CA12—brain—acquired immunodeficiency syndrome	0.00219	0.0289	CbGeAlD
Metolazone—CA4—blood—acquired immunodeficiency syndrome	0.00219	0.0288	CbGeAlD
Metolazone—CA4—bone marrow—acquired immunodeficiency syndrome	0.00212	0.0279	CbGeAlD
Metolazone—CA4—spinal cord—acquired immunodeficiency syndrome	0.00211	0.0278	CbGeAlD
Metolazone—CA5B—brain—acquired immunodeficiency syndrome	0.00197	0.0259	CbGeAlD
Metolazone—CA4—lung—acquired immunodeficiency syndrome	0.00192	0.0253	CbGeAlD
Metolazone—CA5B—lymph node—acquired immunodeficiency syndrome	0.0019	0.025	CbGeAlD
Metolazone—CA4—nervous system—acquired immunodeficiency syndrome	0.00178	0.0234	CbGeAlD
Metolazone—CA4—central nervous system—acquired immunodeficiency syndrome	0.00171	0.0225	CbGeAlD
Metolazone—CA4—brain—acquired immunodeficiency syndrome	0.00136	0.0179	CbGeAlD
Metolazone—CA4—lymph node—acquired immunodeficiency syndrome	0.00131	0.0173	CbGeAlD
Metolazone—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00105	0.00113	CcSEcCtD
Metolazone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00105	0.00113	CcSEcCtD
Metolazone—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Metolazone—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Metolazone—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Metolazone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00104	0.00113	CcSEcCtD
Metolazone—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00112	CcSEcCtD
Metolazone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00104	0.00112	CcSEcCtD
Metolazone—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00112	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00112	CcSEcCtD
Metolazone—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00112	CcSEcCtD
Metolazone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00103	0.00112	CcSEcCtD
Metolazone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00103	0.00112	CcSEcCtD
Metolazone—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00112	CcSEcCtD
Metolazone—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00111	CcSEcCtD
Metolazone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00103	0.00111	CcSEcCtD
Metolazone—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00111	CcSEcCtD
Metolazone—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Metolazone—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Metolazone—Rash—Didanosine—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Metolazone—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Metolazone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00102	0.00111	CcSEcCtD
Metolazone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00102	0.0011	CcSEcCtD
Metolazone—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00102	0.0011	CcSEcCtD
Metolazone—Headache—Didanosine—acquired immunodeficiency syndrome	0.00102	0.0011	CcSEcCtD
Metolazone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00101	0.0011	CcSEcCtD
Metolazone—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00109	CcSEcCtD
Metolazone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.001	0.00109	CcSEcCtD
Metolazone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.001	0.00108	CcSEcCtD
Metolazone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.001	0.00108	CcSEcCtD
Metolazone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000999	0.00108	CcSEcCtD
Metolazone—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000997	0.00108	CcSEcCtD
Metolazone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000996	0.00108	CcSEcCtD
Metolazone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000995	0.00108	CcSEcCtD
Metolazone—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000993	0.00107	CcSEcCtD
Metolazone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000992	0.00107	CcSEcCtD
Metolazone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000992	0.00107	CcSEcCtD
Metolazone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000989	0.00107	CcSEcCtD
Metolazone—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000989	0.00107	CcSEcCtD
Metolazone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000989	0.00107	CcSEcCtD
Metolazone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000986	0.00107	CcSEcCtD
Metolazone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000981	0.00106	CcSEcCtD
Metolazone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000981	0.00106	CcSEcCtD
Metolazone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00098	0.00106	CcSEcCtD
Metolazone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00098	0.00106	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000979	0.00106	CcSEcCtD
Metolazone—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000979	0.00106	CcSEcCtD
Metolazone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000973	0.00105	CcSEcCtD
Metolazone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000973	0.00105	CcSEcCtD
Metolazone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000972	0.00105	CcSEcCtD
Metolazone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000972	0.00105	CcSEcCtD
Metolazone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00097	0.00105	CcSEcCtD
Metolazone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000968	0.00105	CcSEcCtD
Metolazone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000967	0.00105	CcSEcCtD
Metolazone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000966	0.00105	CcSEcCtD
Metolazone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000965	0.00104	CcSEcCtD
Metolazone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000965	0.00104	CcSEcCtD
Metolazone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000963	0.00104	CcSEcCtD
Metolazone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000963	0.00104	CcSEcCtD
Metolazone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000961	0.00104	CcSEcCtD
Metolazone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000959	0.00104	CcSEcCtD
Metolazone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000958	0.00104	CcSEcCtD
Metolazone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000955	0.00103	CcSEcCtD
Metolazone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000955	0.00103	CcSEcCtD
Metolazone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000955	0.00103	CcSEcCtD
Metolazone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000951	0.00103	CcSEcCtD
Metolazone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000949	0.00103	CcSEcCtD
Metolazone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000946	0.00102	CcSEcCtD
Metolazone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000943	0.00102	CcSEcCtD
Metolazone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00094	0.00102	CcSEcCtD
Metolazone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000937	0.00101	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000937	0.00101	CcSEcCtD
Metolazone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000936	0.00101	CcSEcCtD
Metolazone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000934	0.00101	CcSEcCtD
Metolazone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000934	0.00101	CcSEcCtD
Metolazone—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000934	0.00101	CcSEcCtD
Metolazone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000933	0.00101	CcSEcCtD
Metolazone—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000931	0.00101	CcSEcCtD
Metolazone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000931	0.00101	CcSEcCtD
Metolazone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00093	0.00101	CcSEcCtD
Metolazone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00093	0.00101	CcSEcCtD
Metolazone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000927	0.001	CcSEcCtD
Metolazone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000927	0.001	CcSEcCtD
Metolazone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000923	0.000999	CcSEcCtD
Metolazone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000919	0.000995	CcSEcCtD
Metolazone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000919	0.000995	CcSEcCtD
Metolazone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000919	0.000994	CcSEcCtD
Metolazone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000918	0.000994	CcSEcCtD
Metolazone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000917	0.000992	CcSEcCtD
Metolazone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000914	0.000989	CcSEcCtD
Metolazone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000913	0.000988	CcSEcCtD
Metolazone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000911	0.000986	CcSEcCtD
Metolazone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000911	0.000986	CcSEcCtD
Metolazone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000908	0.000982	CcSEcCtD
Metolazone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000906	0.000981	CcSEcCtD
Metolazone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000905	0.000979	CcSEcCtD
Metolazone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000904	0.000978	CcSEcCtD
Metolazone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.0009	0.000974	CcSEcCtD
Metolazone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.0009	0.000974	CcSEcCtD
Metolazone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000899	0.000973	CcSEcCtD
Metolazone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000898	0.000971	CcSEcCtD
Metolazone—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000896	0.00097	CcSEcCtD
Metolazone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000895	0.000968	CcSEcCtD
Metolazone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000894	0.000967	CcSEcCtD
Metolazone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000891	0.000964	CcSEcCtD
Metolazone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00089	0.000963	CcSEcCtD
Metolazone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000889	0.000962	CcSEcCtD
Metolazone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000887	0.00096	CcSEcCtD
Metolazone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000887	0.000959	CcSEcCtD
Metolazone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000886	0.000959	CcSEcCtD
Metolazone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000886	0.000958	CcSEcCtD
Metolazone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000884	0.000957	CcSEcCtD
Metolazone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000882	0.000954	CcSEcCtD
Metolazone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000881	0.000954	CcSEcCtD
Metolazone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000879	0.000952	CcSEcCtD
Metolazone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000879	0.000952	CcSEcCtD
Metolazone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000879	0.000951	CcSEcCtD
Metolazone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000878	0.00095	CcSEcCtD
Metolazone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000874	0.000946	CcSEcCtD
Metolazone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000873	0.000945	CcSEcCtD
Metolazone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000872	0.000944	CcSEcCtD
Metolazone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000869	0.00094	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000866	0.000937	CcSEcCtD
Metolazone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000866	0.000937	CcSEcCtD
Metolazone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000865	0.000936	CcSEcCtD
Metolazone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00086	0.000931	CcSEcCtD
Metolazone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000859	0.00093	CcSEcCtD
Metolazone—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000855	0.000925	CcSEcCtD
Metolazone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000854	0.000924	CcSEcCtD
Metolazone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000854	0.000924	CcSEcCtD
Metolazone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00085	0.000919	CcSEcCtD
Metolazone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000847	0.000917	CcSEcCtD
Metolazone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000845	0.000915	CcSEcCtD
Metolazone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000841	0.00091	CcSEcCtD
Metolazone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000838	0.000907	CcSEcCtD
Metolazone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000838	0.000907	CcSEcCtD
Metolazone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000837	0.000906	CcSEcCtD
Metolazone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000837	0.000906	CcSEcCtD
Metolazone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000836	0.000905	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000834	0.000902	CcSEcCtD
Metolazone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000832	0.000901	CcSEcCtD
Metolazone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000828	0.000896	CcSEcCtD
Metolazone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000827	0.000895	CcSEcCtD
Metolazone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000823	0.000891	CcSEcCtD
Metolazone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000822	0.000889	CcSEcCtD
Metolazone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00082	0.000887	CcSEcCtD
Metolazone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000817	0.000884	CcSEcCtD
Metolazone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000816	0.000883	CcSEcCtD
Metolazone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000814	0.00088	CcSEcCtD
Metolazone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000813	0.00088	CcSEcCtD
Metolazone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000813	0.00088	CcSEcCtD
Metolazone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000813	0.00088	CcSEcCtD
Metolazone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000809	0.000875	CcSEcCtD
Metolazone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000806	0.000872	CcSEcCtD
Metolazone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000805	0.000871	CcSEcCtD
Metolazone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000796	0.000861	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000796	0.000861	CcSEcCtD
Metolazone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000792	0.000857	CcSEcCtD
Metolazone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00079	0.000855	CcSEcCtD
Metolazone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000789	0.000854	CcSEcCtD
Metolazone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000784	0.000848	CcSEcCtD
Metolazone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000784	0.000848	CcSEcCtD
Metolazone—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000783	0.000847	CcSEcCtD
Metolazone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000783	0.000847	CcSEcCtD
Metolazone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000778	0.000842	CcSEcCtD
Metolazone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000778	0.000842	CcSEcCtD
Metolazone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000778	0.000841	CcSEcCtD
Metolazone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000776	0.00084	CcSEcCtD
Metolazone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000771	0.000835	CcSEcCtD
Metolazone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000771	0.000834	CcSEcCtD
Metolazone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000771	0.000834	CcSEcCtD
Metolazone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000769	0.000832	CcSEcCtD
Metolazone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000766	0.000829	CcSEcCtD
Metolazone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00076	0.000823	CcSEcCtD
Metolazone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000759	0.000821	CcSEcCtD
Metolazone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000758	0.00082	CcSEcCtD
Metolazone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000755	0.000817	CcSEcCtD
Metolazone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000754	0.000816	CcSEcCtD
Metolazone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000753	0.000815	CcSEcCtD
Metolazone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000752	0.000814	CcSEcCtD
Metolazone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000752	0.000813	CcSEcCtD
Metolazone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000748	0.00081	CcSEcCtD
Metolazone—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000747	0.000808	CcSEcCtD
Metolazone—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000747	0.000808	CcSEcCtD
Metolazone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000738	0.000798	CcSEcCtD
Metolazone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000735	0.000796	CcSEcCtD
Metolazone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000728	0.000787	CcSEcCtD
Metolazone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000727	0.000787	CcSEcCtD
Metolazone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000727	0.000786	CcSEcCtD
Metolazone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000724	0.000783	CcSEcCtD
Metolazone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000723	0.000783	CcSEcCtD
Metolazone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00072	0.000779	CcSEcCtD
Metolazone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000717	0.000776	CcSEcCtD
Metolazone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000717	0.000775	CcSEcCtD
Metolazone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000714	0.000773	CcSEcCtD
Metolazone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000713	0.000771	CcSEcCtD
Metolazone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000711	0.000769	CcSEcCtD
Metolazone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000704	0.000761	CcSEcCtD
Metolazone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000701	0.000758	CcSEcCtD
Metolazone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000694	0.000751	CcSEcCtD
Metolazone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00069	0.000747	CcSEcCtD
Metolazone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000683	0.000739	CcSEcCtD
Metolazone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000682	0.000738	CcSEcCtD
Metolazone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00068	0.000736	CcSEcCtD
Metolazone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000678	0.000733	CcSEcCtD
Metolazone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000677	0.000733	CcSEcCtD
Metolazone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000676	0.000731	CcSEcCtD
Metolazone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000674	0.00073	CcSEcCtD
Metolazone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000673	0.000729	CcSEcCtD
Metolazone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000673	0.000728	CcSEcCtD
Metolazone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000657	0.000711	CcSEcCtD
Metolazone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000654	0.000707	CcSEcCtD
Metolazone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000651	0.000704	CcSEcCtD
Metolazone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000648	0.000702	CcSEcCtD
Metolazone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000648	0.000701	CcSEcCtD
Metolazone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000648	0.000701	CcSEcCtD
Metolazone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000644	0.000697	CcSEcCtD
Metolazone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000643	0.000696	CcSEcCtD
Metolazone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000638	0.000691	CcSEcCtD
Metolazone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000629	0.00068	CcSEcCtD
Metolazone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000626	0.000678	CcSEcCtD
Metolazone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000626	0.000678	CcSEcCtD
Metolazone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000618	0.000668	CcSEcCtD
Metolazone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000611	0.000661	CcSEcCtD
Metolazone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.000655	CcSEcCtD
Metolazone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000605	0.000654	CcSEcCtD
Metolazone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.0006	0.000649	CcSEcCtD
Metolazone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000599	0.000648	CcSEcCtD
Metolazone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000597	0.000646	CcSEcCtD
Metolazone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000596	0.000645	CcSEcCtD
Metolazone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000582	0.00063	CcSEcCtD
Metolazone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000577	0.000625	CcSEcCtD
Metolazone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000577	0.000624	CcSEcCtD
Metolazone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000577	0.000624	CcSEcCtD
Metolazone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000573	0.00062	CcSEcCtD
Metolazone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000565	0.000611	CcSEcCtD
Metolazone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000555	0.000601	CcSEcCtD
Metolazone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000551	0.000596	CcSEcCtD
Metolazone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00055	0.000595	CcSEcCtD
Metolazone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000547	0.000592	CcSEcCtD
Metolazone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000544	0.000588	CcSEcCtD
Metolazone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000519	0.000561	CcSEcCtD
